Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Betahistine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 known ✓ | Q9Y5N1 | 1/20 | 1.00 |
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.96 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.96 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.96 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.80 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | APP | P05067 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Betahistine SCHEMBL29354603 | 1.00 | HRH3 (1.00) | HRH3LMNAALDH1A1TAAR1ALOX15 | |
| Betahistine SCHEMBL28346535 | 1.00 | HRH3 (1.00) | HRH3LMNAALDH1A1TAAR1ALOX15 | |
| Betahistine SCHEMBL20421889 | 0.98 | HRH3 (0.96) | HRH3LMNAALDH1A1TAAR1ALOX15 | |
| Betahistine SCHEMBL20639365 | 0.98 | HRH3 (0.96) | HRH3LMNAALDH1A1TAAR1ALOX15 | |
| Betahistine SCHEMBL11315542 | 0.98 | HRH3 (0.96) | HRH3LMNAALDH1A1TAAR1ALOX15 | |
| Betahistine SCHEMBL60646 | 0.98 | LMNA (1.00) | HRH3LMNAALDH1A1TAAR1ALOX15 | |
| Betahistine SCHEMBL20421886 | 0.98 | HRH3 (0.96) | HRH3LMNAALDH1A1TAAR1ALOX15 | |
| Betahistine SCHEMBL654358 | 0.98 | LMNA (1.00) | HRH3LMNAALDH1A1TAAR1ALOX15 | |
| Betahistine SCHEMBL1649204 | 0.98 | HRH3 (0.96) | HRH3LMNAALDH1A1TAAR1ALOX15 | |
| Betahistine SCHEMBL5373612 | 0.96 | LMNA (0.96) | HRH3LMNAALDH1A1TAAR1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5731 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036817-A | C-alkyl carbon glycoside and preparation method thereof | 江西师范大学 | 2026-05-15 | — | — | CN | claimed |
| EP-4731194-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP Technologies, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4687805-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING ACTIVATED CARBON OR A DERIVATIVE THEREOF | CSP Technologies, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260027008-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING ACTIVATED CARBON OR A DERIVATIVE THEREOF | CSP TECHNOLOGIES, INC. | 2026-01-29 | — | — | US | claimed |
| EP-4673146-A2 | METHODS FOR TREATING OBSESSIVE COMPULSIVE RELATED DISORDERS, TIC DISORDERS AND GLUTAMATE EXCITOTOXICITY RELATED DISORDERS | Biohaven Therapeutics Ltd. (VG) | 2026-01-07 | — | — | EP | claimed |
| WO-2025264260-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP TECHNOLOGIES, INC. (US) | 2025-12-26 | — | — | WO | claimed |
| US-12472186-B2 | Pharmaceutical compositions and methods of treating cardiovascular diseases | Cardix Therapeutics LLC (US) | 2025-11-18 | — | — | US | claimed |
| EP-4633614-A1 | STABLE PHARMACEUTICAL COMPOSITION OF AN AMINE DRUG | Sun Pharmaceutical Industries Limited (IN) | 2025-10-22 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| EP-0397025-B1 | [2-(2-pyridyl)ethyl]-methylamine salts | PRODOTTI FORMENTI (IT) | 1994-01-12 | — | — | EP | claimed |
| US-5221535-A | Sustained release formulations of insect repellent | NOVA PHARMACEUTICAL CORPORATION (US) | 1993-06-22 | — | — | US | claimed |
| EP-0502119-A1 | LIPOSPHERES FOR CONTROLLED DELIVERY OF SUBSTANCES. | NOVA PHARM CORP (US) | 1992-09-09 | — | — | EP | claimed |
| EP-0502642-A1 | Sustained release compositions | RECKITT AND COLMAN PRODUCTS LIMITED (GB) | 1992-09-09 | — | — | EP | claimed |
| US-5132115-A | PLANAR THERAPEUTIC SYSTEM, PROCESS FOR ITS PRODUCTION AND UTILIZATION | LOHMANN GMBH & CO., KG, A GERMAN CORP. (DE) | 1992-07-21 | — | — | US | claimed |
| EP-0242827-B1 | SURFACE SHAPED THERAPEUTIC SYSTEM, METHOD FOR ITS MANUFACTURE, AND ITS APPLICATION | Lohmann GmbH & Co. KG (DE) | 1991-12-27 | — | — | EP | claimed |
| WO-1991007171-A1 | LIPOSPHERES FOR CONTROLLED DELIVERY OF SUBSTANCES | NOVA PHARMACEUTICAL CORPORATION (US) | 1991-05-30 | — | — | WO | claimed |
| EP-0397025-A1 | [2-(2-pyridyl)ethyl]-methylamine salts | PRODOTTI FORMENTI S.r.l. (IT) | 1990-11-14 | — | — | EP | claimed |
| US-4395311-A | Preparation of aminomethanols | THE DOW CHEMICAL COMPANY (US) | 1983-07-26 | — | — | US | claimed |
| US-4159332-A | Prevention of or reduction in severity of myocardial infarction | UNIMED, INC. (US) | 1979-06-26 | — | — | US | claimed |